PHR - Phreesia, Inc.
After hours:
| Previous close | 30.88 |
| Open | 31.31 |
| Bid | 31.24 x 1100 |
| Ask | 34.20 x 800 |
| Day's range | 30.81 - 32.75 |
| 52-week range | 16.78 - 40.00 |
| Volume | |
| Avg. volume | 440,822 |
| Market cap | 1.852B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.48 |
| Earnings date | 31 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 39.00 |
ZacksPhreesia (PHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended April 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksPhreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 12.50% and 3.97%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WirePhreesia Announces First Quarter Fiscal 2024 Results
WILMINGTON, Del., May 31, 2023--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023.
Business WirePhreesia Recognized as One of Modern Healthcare’s "Best Places to Work in Healthcare" for a Seventh Year
WILMINGTON, Del., May 17, 2023--Phreesia has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare.
Business WirePhreesia’s Hilary Hatch Named a "Disrupter" in PM360’s ELITE 100
WILMINGTON, Del., May 16, 2023--Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360.
ZacksTivic Health Systems, Inc. (TIVC) Reports Q1 Loss, Lags Revenue Estimates
Tivic Health Systems, Inc. (TIVC) delivered earnings and revenue surprises of 0% and 27.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksHomology Medicines (FIXX) Reports Q1 Loss, Lags Revenue Estimates
Homology Medicines (FIXX) delivered earnings and revenue surprises of 9.09% and 40.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksInvitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates
Invitae (NVTA) delivered earnings and revenue surprises of 9.76% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.Why Investors Shouldn't Be Surprised By Phreesia, Inc.'s (NYSE:PHR) P/S
Phreesia, Inc.'s ( NYSE:PHR ) price-to-sales (or "P/S") ratio of 5.6x may look like a poor investment opportunity when...
ZacksCareCloud, Inc. (CCLD) Reports Q1 Loss, Lags Revenue Estimates
CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of 9.68% and 3.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksInspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 24.29% and 6.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WirePhreesia Sets Release Date for Fiscal First Quarter 2024 Results
WILMINGTON, Del., April 25, 2023--Phreesia, Inc. will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023.
Business WireUnlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
CINCINNATI & WILMINGTON, Del., March 29, 2023--Unlimited Systems and Phreesia are offering a new integration for independent oncology practices and health systems.
- Simply Wall St.
Investors might be losing patience for Phreesia's (NYSE:PHR) increasing losses, as stock sheds 6.4% over the past week
Phreesia, Inc. ( NYSE:PHR ) shareholders have seen the share price descend 11% over the month. But that doesn't change...
ZacksPhreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WirePhreesia Announces Chief Financial Officer Transition
WILMINGTON, Del., March 22, 2023--Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities.
Business WirePhreesia Announces Fourth Quarter Fiscal 2023 Results
WILMINGTON, Del., March 22, 2023--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023.
Business WirePhreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
WILMINGTON, Del., March 20, 2023--Phreesia has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®.
Business WirePhreesia’s Alexandra Beneville Named One of MM+M’s ‘Women to Watch’ for 2023
WILMINGTON, Del., March 17, 2023--Phreesia announces that MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.
Business WirePhreesia’s Dan Nathan Named as a Top Software CTO of 2023
WILMINGTON, Del., March 15, 2023--Phreesia is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named as one of the Top 25 Software CTOs of 2023.
ZacksSonendo, Inc. (SONX) Reports Q4 Loss, Tops Revenue Estimates
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of 45.45% and 5.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksCooper Companies (COO) to Post Q1 Earnings: What's in Store?
Cooper Companies' (COO) fiscal first-quarter results are likely to reflect segmental strength.
- Zacks
What's in Store for Patterson Companies (PDCO) in Q3 Earnings?
Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect an improvement at the Animal Health segment.
ZacksWhat Makes Phreesia (PHR) a New Buy Stock
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksPhreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
